NOK 14.0
(-6.35%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 7.66 Million NOK | 75.95% |
2022 | 4.35 Million NOK | 61.44% |
2021 | 2.69 Million NOK | 0.0% |
2020 | - NOK | 0.0% |
2019 | - NOK | 0.0% |
2018 | - NOK | 0.0% |
2017 | - NOK | 0.0% |
2016 | - NOK | 0.0% |
2015 | - NOK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 10.1 Million NOK | 0.0% |
2024 Q1 | 4.57 Million NOK | 0.0% |
2023 Q2 | 7.55 Million NOK | 0.0% |
2023 Q4 | - NOK | 0.0% |
2023 FY | 7.66 Million NOK | 75.95% |
2023 Q1 | - NOK | -100.0% |
2023 Q3 | - NOK | -100.0% |
2022 Q3 | - NOK | -100.0% |
2022 FY | 4.35 Million NOK | 61.44% |
2022 Q2 | 6.41 Million NOK | 0.0% |
2022 Q4 | 4.35 Million NOK | 0.0% |
2021 Q4 | 2.69 Million NOK | 0.0% |
2021 FY | 2.69 Million NOK | 0.0% |
2021 Q2 | 3.35 Million NOK | 0.0% |
2020 Q4 | - NOK | 0.0% |
2020 FY | - NOK | 0.0% |
2019 Q4 | - NOK | 0.0% |
2019 Q2 | - NOK | 0.0% |
2019 FY | - NOK | 0.0% |
2018 Q4 | - NOK | 0.0% |
2018 Q2 | 2.44 Million NOK | 0.0% |
2018 FY | - NOK | 0.0% |
2017 FY | - NOK | 0.0% |
2017 Q4 | - NOK | 0.0% |
2016 FY | - NOK | 0.0% |
2015 FY | - NOK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Gentian Diagnostics ASA | 9 Million NOK | 14.936% |
Medistim ASA | 9.26 Million NOK | 17.269% |